doxapram has been researched along with Infant, Newborn, Diseases in 3 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylxanthines and doxapram have been used to stimulate breathing and to prevent apnea in preterm infants." | 3.73 | [Determinants of doxapram utilization: a survey of practice in the French Neonatal and Intensive Care Units]. ( Bénard, M; Boutroy, MJ; Casper, C; Glorieux, I, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bénard, M | 1 |
| Boutroy, MJ | 1 |
| Glorieux, I | 1 |
| Casper, C | 1 |
| Gupta, PK | 2 |
| Moore, J | 2 |
| Lewis, MA | 1 |
| Dundee, JW | 1 |
1 trial available for doxapram and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Clinical trial of doxapram hydrochloride in the resuscitation of the newborn.
Topics: Carbon Dioxide; Central Nervous System Stimulants; Doxapram; Humans; Infant, Newborn; Infant, Newbor | 1972 |
2 other studies available for doxapram and Infant, Newborn, Diseases
| Article | Year |
|---|---|
[Determinants of doxapram utilization: a survey of practice in the French Neonatal and Intensive Care Units].
Topics: Apnea; Doxapram; France; Health Care Surveys; Humans; Infant, Newborn; Infant, Newborn, Diseases; In | 2005 |
The use of doxapram in the newborn.
Topics: Anesthesia, Obstetrical; Bicarbonates; Birth Weight; Blood; Carbon Dioxide; Doxapram; Female; Gestat | 1973 |